The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.40
Bid: 2.30
Ask: 2.50
Change: 0.00 (0.00%)
Spread: 0.20 (8.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.40
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Goldplat sells shares; Chill Brands starts campaigns

Mon, 31st Oct 2022 21:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Valereum Blockchain PLC - Gibraltar-based blockchain technology - Receives consent from the Gibraltar Financial Services Commission to complete the acquisition of the Gibraltar Stock Exchange."We have ambitious plans for the GSX and for Valereum linking the fiat and digital worlds. All our expansion plans will be fully regulated in the environments in which we plan to operate. The GSX will harness proven exchange technology from established providers and will be updated with full front to back trading and clearing functionality on a significant scale and expandability," Chair Richard Poulden comments.

----------

Landore Resources Ltd - Mining exploration and development company in Canada - Completes the acquisition of Ardiden Ltd's 20% interest in the Root Lake property. Earlier this month, it finalised and executed an extinguishment agreement with Green Technology Metals Ltd for CAD3 million, or USD2.2 million. Green Technology Metals will extinguish half of Landore's 3% net smelter royalty over the Root Lake property in Ontario, Canada. In return, Green Technology has agreed to pay Landore CAD2 million in cash.

----------

Shield Therapeutics PLC - commercial stage pharmaceutical company - Korean Food & Drug Administration says that a single pharmacokinetic study is the last study required to support a new drug application submission for Accrufer. The drug is an iron-containing medication for the treatment of adults with low iron stores. Expects regulatory approval in Korea in late 2023.

----------

Goldplat PLC - South Africa and Ghana-focused gold miner - Sells a portion of its shares in Caracal Gold PLC. Says it has sold 23.3 million shares in Caracal for 0.65 pence per share. Following the disposal, it retains a 4.3% interest in Caracal.

----------

Infrastructure India PLC - invests in infrastructure assets in India's energy and transport sectors - Notes that the purchaser of Indian Energy Ltd, AVSR Constructions, is continuing to experience administrative delays in finalising the transaction. Says that it has expressed concern to AVSR over the continued delays and stressed that progress must soon be made. Remains in discussions with third parties regarding the sale of assets.

----------

Momentum Multi-Asset Value Trust PLC - London-based investment firm - Renews its GBP10 million revolving credit facility with The Royal Bank of Scotland International Ltd for a further two years. The facility bears interest at 1.35% over Sterling Overnight Index Average and may be used for the acquisition of investments, it says.

----------

Amaroq Minerals Ltd - Greenland-focused gold mining company - Raises CAD29.0 million, or GBP18.6 million, in Iceland through a placing of 53.7 million common shares, which have been issued and admitted in the TSX Venture Exchange today.

----------

DeepVerge PLC - Dublin-based environmental and life science group - Says it extended its broker offer to 1630 GMT on Monday October 31.

----------

Chill Brands Group PLC - Grand Junction, Colorado-based cannabidiol products - Says the Chill.com website generated sales in excess of USD10,000 in the seven days following its relaunch on October 18. Starts "a number" of marketing campaigns that are intended to drive additional traffic to Chill.com. "Our focus has now turned to an array of marketing initiatives that will drive new consumers towards our growing digital sales channel. We still have a long way to go to achieve our ambitions for the Chill.com platform, but this has been a very encouraging start," Chief Executive Callum Sommerton says.

----------

Round Hill Music Royalty Fund Ltd - New York-based music copyright investment company - Anticipates that a number of recent industry updates in streaming will be beneficial to its revenue. "The company's exposure to positive revenue trends in streaming services is significant, with approximately 50% of RHM's revenues derived from digital service providers such as Spotify and Apple Music across master, mechanical and performance royalties," it explains.

----------

Psych Capital PLC - London-based psychedelic medicines media and investor - Posts a maiden pretax loss of GBP543,933 in the year which ended April 30. Records revenue of GBP62,228. Expects the publication of potentially transformative clinical trial results expected in late 2022 or early 2023, with MDMA and psilocybin-assisted therapy expected to be regulated by the FDA.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2023 17:07

CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed

(Correcting the name of Sage Therapeutics Inc. Please ignore incorrect coding of Shield Therapeutics PLC.)

Read more
6 Aug 2023 14:17

Biogens, Sage Therapeutics postpartum depression treatment approved

(Alliance News) - The US Food & Drug Administration has approved Zurzuvae, zuranolone, 50 mg for adults with postpartum depression, Sage Therapeutics PLC and Biogen Inc said in a statement.

Read more
20 Jul 2023 11:43

IN BRIEF: Shield Therapeutics prescription orders up in first quarter

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Sees strong prescription growth in the second quarter and first half of 2023. Total prescriptions for second quarter increase 50% to 15,800 compared to the first quarter. In first half of 2023, total prescriptions grow to around 26,300 which exceeds total prescription volumes for all of 2022. The company says that this growth in the first half means Shield is likely to meet its 2023 goal for US Accrufer prescriptions.

Read more
21 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Braime Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Falcon Oil & Gas LtdAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Robinson PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrant holders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 18:13

IN BRIEF: Shield Therapeutics pretax loss doubles despite revenue rise

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Reports revenue in the year to December 31 trebled to GBP4.5 million from GBP1.5 million a year before. Says net product revenue from sales of Accrufer in the US totalled GBP2.9 million, up from GBP0.1 million while royalty revenue from product sales in Europe reached GBP1.4 million, up from GBP0.9 million.

Read more
5 Apr 2023 12:38

IN BRIEF: Shield appoints Andy Hurley as chief commercial officer

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Appoints Andy Hurley as chief commercial officer, effective from April 10.

Read more
9 Feb 2023 11:19

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
9 Feb 2023 10:50

Shield Therapeutics 2022 revenue jumps on Accrufer iron tablet sales

(Alliance News) - Shield Therapeutics PLC on Thursday said revenue in 2022 rose amid a jump in sales of its Accrufer iron tablets, also known as Feraccru.

Read more
9 Jan 2023 20:41

TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Jan 2023 17:11

Shield Therapeutics completes GBP2.6 million open offer

(Alliance News) - Shield Therapeutics PLC on Thursday said it has raised GBP2.6 million through an open offer.

Read more
29 Dec 2022 13:40

UK shareholder meetings calendar - next 7 days

Friday 30 December 
Amala Foods PLCAGM
Apollon Formularies PLCAGM
Europa Metals LtdGM re Denarius transaction
Goldplat PLCAGM
Ncondezi Energy LtdAGM
Ross GroupAGM
Secure Property Development & Investment PLCAGM
Time Out Group PLCAGM
Monday 02 January 
no events scheduled 
Tuesday 03 January 
no events scheduled 
Wednesday 04 January 
Thor Mining PLCGM re name change to Thor Energy PLC
Borders & Southern Petroleum PLCGM re fundraising
Thursday 05 January 
AfriTin Mining LtdEGM re name change
Shield Therapeutics PLCGM re share transaction
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
13 Dec 2022 16:50

TRADING UPDATES: Longboat Energy extends loan for drilling programme

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Dec 2022 12:06

Shield Therapeutics plans share offer; agrees Accrufer collaboration

(Alliance News) - Shield Therapeutics PLC on Tuesday said it plans a share offer to raise fresh funds, while it also has agreed a sales collaboration with Viatris Inc in the US for the oral therapy Accrufer.

Read more
27 Oct 2022 14:44

TRADING UPDATES: Gusbourne toasts vintage; Hardide supplies Leonardo

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.